# Zatanna -- Sam Lessin Evaluation

Zatanna is the kind of company that triggers every alarm in my framework simultaneously. AI agents for dental billing automation -- let me run my most basic test first: would this business exist if AI didn't exist? The answer is unambiguously no. The entire value proposition is the AI. Strip it away and there's nothing -- no physical operations, no protocol layer, no regulatory position, no network effect. This is a tech company with a paint layer, not a painting company with a tech layer. It sits in exactly the category I've been warning about since 2024: an "AI-powered" version of an existing workflow where the AI capability IS the product. And when AI is the product, the question becomes who has distribution -- and that's not a three-person pre-seed startup entering a market where Overjet has raised $133 million and Trust AI already has 8,000 dentists on its platform.

The sane-person-insane-idea calibration breaks down on both halves. The founders are clearly intelligent -- Coinbase, Amazon, IEEE-published ML research, strong engineering programs. That's generic tech "sane." But "sane" in my framework means domain-credible for THIS specific problem. None of the three founders have any publicly visible experience in dental practice operations, healthcare billing, revenue cycle management, or insurance claims processing. They're building a system meant to codify the "tribal knowledge" of experienced dental billing staff, and there's no signal that any of them have spent meaningful time absorbing that knowledge firsthand. Meanwhile, the idea itself isn't remotely insane -- it's consensus. DentalRobot has been automating dental insurance verification and writing back to twelve-plus PMS systems for five years. Trust AI raised $6.5 million and has thousands of dentists already. When every competitor and their VC backers agree the opportunity is real, you're not buying non-consensus -- you're buying a crowded market at pre-seed scale against better-resourced players.

The moat question is where this completely falls apart for me. The claimed differentiator is a 30,000+ historical EOB dataset. That number needs context: a single mid-sized dental practice processes thousands of claims per year. DentalRobot's five years of dental-specific training likely encompasses orders of magnitude more data. And here's the structural problem -- training data moats in LLM-era AI are dissolving faster than any other moat category. When the underlying models improve, the value of curated domain datasets shrinks because general models get good enough. Zatanna's 30,000 EOBs are a rounding error compared to what a foundation model trained on the entire internet already understands about insurance documentation. The "continuously learning" angle is real but not unique -- every AI system learns from its deployments, and the company that gets to scale first accumulates the compounding advantage. Zatanna is entering this race dead last among its named competitors.

The strongest bull case would go something like this: dental billing is genuinely miserable operational work with insurer-specific rules, appeal processes, and institutional knowledge that creates real barriers to automation quality. If Zatanna's technical team can build demonstrably better agents than DentalRobot or Trust AI -- agents that actually recover more revenue per practice through smarter appeals and pre-emptive AR prevention -- the per-practice ROI story is compelling enough to overcome the late-mover disadvantage. The infrastructure positioning (integrating with existing PMS rather than replacing it, as Trust AI attempts) could be strategically smarter, reducing adoption friction. And dental is potentially just a wedge into the much larger healthcare RCM market. For this to work, you'd need to believe that (a) the founding team's raw technical ability produces a meaningfully superior product despite no domain background, (b) the 30,000 EOB dataset seeds a flywheel that compounds faster than competitors', and (c) the market is big enough for multiple winners. I don't find any of those three assumptions compelling, but I'll acknowledge the theoretical path.

The narrative magnitude problem seals the pass for me. Dental RCM is a $748 million market growing at 5.25%. That's a real market, but it's not an infinity story. The expansion path to broader healthcare billing requires different coding systems (CDT versus CPT/ICD-10), different payer dynamics, and different regulatory knowledge -- it's essentially starting over. Compare this to Venmo, which was a new payment primitive that expanded from peer-to-peer to commerce to financial services, each step making the next one more credible. Zatanna's narrative narrows as you examine it rather than expands. It's a dental billing tool that might become a healthcare billing tool, but in either incarnation it remains an application sitting on top of other companies' infrastructure, vulnerable to those infrastructure players absorbing the functionality.

### Dimension Scores

| Criterion | Score |
|-----------|-------|
| "Sane Person, Insane Idea" Calibration | 8/30 |
| AI-Resistant Structural Moat | 5/25 |
| New Primitive or Protocol Position | 5/20 |
| Narrative Magnitude and Infinity Optionality | 6/15 |
| Real Revenue or Asset Cushion | 3/10 |
| **Total** | **27/100** |

**Total Score: 27/100** (Pass)
